# Top 50 Health Care VC (Venture Capital) Funds in China in June 2026 ## Qiming Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 83 - Stages: Series B, Series A, Series C - Focus: Health Care, Biotechnology, Medical Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status. ## BioVenture - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 63 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation. ## HSG - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 55 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software We help founders build enduring companies. ## Med-Fine Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 46 - Stages: Series A, Seed, Series B - Focus: Medical, Health Care, Biotechnology Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen. ## Lilly Asia Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 41 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto. ## Matrix Partners China - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 38 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Software Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages. ## Frees Fund - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 37 - Stages: Series A, Seed, Angel - Focus: Artificial Intelligence, Health Care, Biotechnology By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology. ## IDG Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 36 - Stages: Series A, Series B, Series C - Focus: Software, Internet, E-Commerce IDG Capital is a global investment firm partnering with founders to build enduring businesses through capital, expertise, and long-term support. ## Legend Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 34 - Stages: Series B, Series A, Series C - Focus: Health Care, Medical, Biotechnology Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry. ## Highlight Capital - Type: VC Fund - Location: Nanjin, Jiangsu, China - Relevant deals: 34 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect. ## BioTrack Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 32 - Stages: Series A, Series B, Seed - Focus: Biotechnology, Health Care, Medical BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones. ## Kaitai Capital - Type: VC Fund - Location: Hangzhou, Zhejiang, China - Relevant deals: 32 - Stages: Series A, Series B, Angel - Focus: Biotechnology, Health Care, Pharmaceutical KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc. ## Marathon Venture Partners - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 31 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry. ## Puhua Capital - Type: VC Fund - Location: Hangzhou, Zhejiang, China - Relevant deals: 30 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Manufacturing Puhua Capital is an equity investment firm that focuses on early and middle project. Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups. ## Dalton Venture - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 29 - Stages: Seed, Series A, Series B - Focus: Health Care, Medical, Biotechnology Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health. ## Cowin Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 29 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Health Care, Biotechnology Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market. ## Northern Light Venture Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 28 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential. ## Legend Star - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 28 - Stages: Series A, Seed, Angel - Focus: Health Care, Medical, Biotechnology Legend Star helps entrepreneurs create great businesses through investments, CEO training sessions and an entrepreneurs alliance.Since 2008, Legend Star has incubated and invested in nearly 600 companies and is deeply integrated in the Chinese entrepreneurial ecosystem.Legend Star is the independent early-stage investment arm of LegendHoldings. Legend Holdings is the parent company of Lenovo, Raycom Real Estate, Joyvio Agribusiness and a large range of fast-growing Chinese companies. ## Sherpa Healthcare Partners - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 27 - Stages: Series A, Series B, Series C - Focus: Biotechnology, Health Care, Medical Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China. ## CDH Investments - Type: VC Fund - Location: Kowloon City, Kowloon, Hong Kong - Relevant deals: 27 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Biotechnology CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China. ## CD Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 27 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Medical Device CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors. ## Shanghai Biomedical Industrial Equity Investment Fund - Type: VC Fund - Location: Huangpu, Shanghai, China - Relevant deals: 27 - Stages: Series A, Seed, Series B - Focus: Health Care, Medical, Biotechnology Shanghai Biomedical Industrial Equity focuses on areas that are in line with the development strategy of the biomedical industry. ## Share Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 23 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Share Capital is a venture capital firm specializing in seed, start-up, early, middle, growth capital, and Pre-IPO investments. it primarily invests in big living, medical healthcare, and internet innovation. In medical healthcare, it seeks to invests in pharmaceuticals, innovative equipment, biotechnology, diagnostic testing equipment andreagents, anti-infectives, drug discovery, medical health service, mobile medical services, and informatization. ## Cowin Venture - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 22 - Stages: Series A, Angel, Series B - Focus: Health Care, Medical, Biotechnology Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong. ## Shenzhen Capital Group - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 22 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Software Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide. ## Lenovo Capital and Incubator Group (LCIG) - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 21 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Artificial Intelligence, Software Lenovo Capital and Incubator Group is an accelerator and venture capital firm. ## Prox Ventures - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 21 - Stages: Seed, Series A - Focus: Medical, Biotechnology, Health Care Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health. ## TF Capital - Type: VC Fund - Location: Pudong, Shandong, China - Relevant deals: 21 - Stages: Series A, Series B - Focus: Biotechnology, Health Care, Medical TF Capital is a proprietary trading company that specializes in foreign exchange and invests in early stage ventures. ## Gaorong Capital - Type: VC Fund - Location: Wangjing, Beijing, China - Relevant deals: 20 - Stages: Series A, Series B, Seed - Focus: Information Technology, Software, Artificial Intelligence Gaorong Capital is a venture capital firm that focuses on early and growth stage investments in TMT, including AI and frontier technologies. ## Huagai Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 20 - Stages: Series A, Series B, Angel - Focus: Health Care, Biotechnology, Medical Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture. ## Oriza Holdings - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 20 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Health Care, Biotechnology Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007. ## Oriza Seed Capital (Oriza Yuandian) - Type: VC Fund - Location: Suzhou, Jiangsu, China - Relevant deals: 19 - Stages: Series A, Seed, Angel - Focus: Manufacturing, Health Care, Biotechnology Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation. ## Volcanics Venture - Type: VC Fund - Location: Changning, Shanghai, China - Relevant deals: 19 - Stages: Series A, Series B - Focus: Health Care, Artificial Intelligence, Biotechnology Volcanics Venture was founded in May 2016. They identify, invest in, and serve the most promising companies and outstanding entrepreneurs in Internet Innovation, Intelligent Technology and Healthcare industry. Managing Partners Suyang Zhang, Yeshun Dong and Ying Wu have been working closely for years as first-class USD/RMB fund managers.They have more than 60 years of aggregated VC investment and corporate management experience, as well as in-depth understanding of three focused fields. Volcanics Venture brings a powerful combination of global perspective and local experience to investment management, striving to provide sustainable value-added service to their portfolio companies and bring superior return to their limited partners. ## Hillhouse Investment - Type: VC Fund - Location: Changyang, Beijing, China - Relevant deals: 18 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Software Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions. ## Green Pine Capital Partners - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 18 - Stages: Series A, Series B, Angel - Focus: Biotechnology, Software, Manufacturing Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China. ## Sinopharm Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 18 - Stages: Series A, Series B, Seed - Focus: Health Care, Biotechnology, Medical Sinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation that specializes in medical and healthcare, pharmaceuticals, biotechnology, medical devices, healthcare and medical supply, and services for elderly and persons with disability. It seeks to invest in China. Sinopharm Capital was founded in June 2012 and isbased in Shanghai, China. ## ZhenFund - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 18 - Stages: Series A, Seed, Angel - Focus: Artificial Intelligence, Software, E-Commerce ZhenFund is a seed fund founded by former entrepreneurs to invest in the most promising innovators. New Oriental co-founders Bob Xiaoping Xu and Victor Qiang Wang established ZhenFund in 2011 in collaboration with Sequoia Capital China. ZhenFund now has a network of over 800 portfolio companies, including over 30 unicorns based in China. Webelieve that great businesses start with exceptional founding teams. We are dedicated to helping our entrepreneurs build successful companies by providing them with mentorship and the best resources available. Some of our services include biannual demo days to top Chinese VCs, ZhenHR services, marketing and PR consulting, as well as fundraising. Our strong and large CEO network also facilitates entrepreneurs helping each other, especially via our WeChat platform. ZhenFund has been ranked as the “#1 Early-Stage Investment Firm” for six years. Bob Xiaoping Xu, Founder of ZhenFund, has been named on the Midas List since 2016 and ranked #11 in 2019. Anna Fang, Founding Partner and CEO of ZhenFund, has been named on the Midas List since 2019 and made her 4th appearance as #12, and #1 on Midas Seed List in 2022. ## CASH Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 18 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Manufacturing CASH invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth stage. ## ZSVC - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 18 - Stages: Series A, Seed, Series B - Focus: Manufacturing, Medical, Health Care ZSVC is a Chinese venture capital firm specialized in seed and early stage investments. ## Oriental Fortune Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 17 - Stages: Series A, Series B, Seed - Focus: Software, Manufacturing, Information Technology Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China. ## LYFE Capital - Type: VC Fund - Location: Shanghai, Shanghai, China - Relevant deals: 17 - Stages: Series B, Series A, Series C - Focus: Biotechnology, Health Care, Medical LYFE Capital is a pure play healthcare focused investment firm. We believe that “Healthcare has no boundaries”, and that every new choice we made has the potential to advance healthcare and solve the unmet needs for everyone. LYFE Capital operates 5 global offices including our US headquarters in Menlo Park, California, our Asia headquarters inSingapore, as well as locations in Seoul, Tokyo and Shanghai. We leverage our expertise and global resources to invest in and create value for healthcare companies across the globe. LYFE Capital’s investments span medical devices, therapeutics, diagnostics, and emerging sectors across North America and Asia. ## Lotus Lake Ventures - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 17 - Stages: Series A, Series B, Seed - Focus: Health Care, Medical, Biotechnology Lotus Lake Ventures is an investment firm committed to investing in science and technology innovation enterprises, focusing on high-tech and high-tech enterprises with core competitiveness in the initial stage and growth stage.. ## Sinovation Ventures - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 17 - Stages: Series A, Seed, Series B - Focus: Software, Artificial Intelligence, Internet Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market. ## Tiantu Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 17 - Stages: Series A, Series B, Series C - Focus: Food and Beverage, E-Commerce, Medical Tiantu Capital is a venture capital association. ## Plum Ventures - Type: VC Fund - Location: Changzhou, Zhejiang, China - Relevant deals: 17 - Stages: Series A, Angel, Seed - Focus: E-Commerce, Manufacturing, Software Plum Ventures is a venture capital company that aims to encourage young people to become entrepreneurs. It specializes ins providing seed and early-stage investments in the technology, new media, and telecommunications industry. The firm was founded in May 2014 and is based in Changzhou, China. ## Delian Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 17 - Stages: Series A, Seed, Series B - Focus: Biotechnology, Manufacturing, Health Care Founded in 2011, Delian Capital specializes in the field of tech-driven industry such as high-end manufacturing, cutting-edge technologies, and healthcare. Their investments range from robotics, Smart manufacturing Semiconductor, AI, big data, enterpriseservices, healthcare, etc.Examples of their investment portfolio: YueBoo、Hunan zhongli、Esafenet、Venus MedTech、MicuRx、Rokae、 IMI、12 Sigma Technologies. ## EFung Capital - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 17 - Stages: Series A, Series B, Series C - Focus: Health Care, Biotechnology, Medical Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion. ## Addor Capital - Type: VC Fund - Location: Nanjing, Jiangsu, China - Relevant deals: 17 - Stages: Series A, Series B - Focus: Manufacturing, Semiconductor, Electronics Addor Capital offers investment services by financing early stage ventures and holding securities of other companies. ## Shenzhen Guozhong Venture Capital Management - Type: VC Fund - Location: Shenzhen, Guangdong, China - Relevant deals: 16 - Stages: Series A, Series B, Seed - Focus: Manufacturing, Health Care, Biotechnology Shenzhen Guozhong Venture Capital Management CO. LTD.(GZVCM) was founded on 21st of December 2015, currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund（SHENZHEN）LLP with a size of 6 Billion Yuan.Guozhong Venture Capital with a registered size of 100million Yuan, partners consisting Shenzhenventure capital group (49%) and the management team of Small Medium Enterprise Development Fund (SHENZHEN) (51%). ## Shunwei Capital - Type: VC Fund - Location: Beijing, Beijing, China - Relevant deals: 16 - Stages: Series A, Series B, Series C - Focus: Manufacturing, Software, Internet Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.